Regeneron Pharmaceuticals Inc (REGN)
962.07
-7.90
(-0.81%)
USD |
NASDAQ |
May 08, 10:54
Regeneron Pharmaceuticals Market Cap: 106.01B for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 07, 2024 | 106.88B |
| May 06, 2024 | 105.63B |
| May 03, 2024 | 105.45B |
| May 02, 2024 | 103.31B |
| May 01, 2024 | 99.55B |
| April 30, 2024 | 98.14B |
| April 29, 2024 | 98.34B |
| April 26, 2024 | 97.32B |
| April 25, 2024 | 98.14B |
| April 24, 2024 | 99.89B |
| April 23, 2024 | 99.97B |
| April 22, 2024 | 99.18B |
| April 19, 2024 | 98.82B |
| April 18, 2024 | 98.50B |
| April 17, 2024 | 99.30B |
| April 16, 2024 | 98.52B |
| April 15, 2024 | 99.01B |
| April 12, 2024 | 99.68B |
| April 11, 2024 | 101.41B |
| April 10, 2024 | 103.16B |
| April 09, 2024 | 104.00B |
| April 08, 2024 | 103.41B |
| April 05, 2024 | 103.87B |
| April 04, 2024 | 103.25B |
| April 03, 2024 | 104.78B |
| Date | Value |
|---|---|
| April 02, 2024 | 105.19B |
| April 01, 2024 | 106.80B |
| March 28, 2024 | 105.64B |
| March 27, 2024 | 106.06B |
| March 26, 2024 | 105.76B |
| March 25, 2024 | 105.49B |
| March 22, 2024 | 106.17B |
| March 21, 2024 | 106.25B |
| March 20, 2024 | 106.14B |
| March 19, 2024 | 105.77B |
| March 18, 2024 | 105.36B |
| March 15, 2024 | 105.86B |
| March 14, 2024 | 105.27B |
| March 13, 2024 | 105.97B |
| March 12, 2024 | 106.53B |
| March 11, 2024 | 105.86B |
| March 08, 2024 | 106.34B |
| March 07, 2024 | 106.83B |
| March 06, 2024 | 106.70B |
| March 05, 2024 | 105.94B |
| March 04, 2024 | 106.60B |
| March 01, 2024 | 107.88B |
| February 29, 2024 | 106.04B |
| February 28, 2024 | 108.40B |
| February 27, 2024 | 109.03B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
30.03B
Minimum
Sep 27 2019
109.03B
Maximum
Feb 27 2024
66.68B
Average
66.25B
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 109.53B |
| Amgen Inc | 164.07B |
| Eli Lilly and Co | 738.70B |
| Moderna Inc | 46.71B |
| Gilead Sciences Inc | 81.22B |
Market Cap Related Metrics
| PE Ratio | 28.42 |
| PS Ratio | 8.374 |
| Price to Book Value | 3.927 |
| Price to Free Cash Flow | 27.91 |
| Price | 962.07 |
| Earnings Yield | 3.52% |
| Operating PE Ratio | 27.50 |
| Normalized PE Ratio | 26.25 |